Bioequivalence study of Glimepride Tablet [Study As­sess­ment]

posted by Ibrahim Komeil – Egypt, 2021-02-15 10:07 (64 d 11:51 ago) – Posting: # 22208
Views: 410

Dear All
I hope you are all fine
Recently i had got results of bioequivalence study for Glimepride Tablet 1 mg applying two way crossover design with 26 volunteers
The results are shown below:
Cmax: PI = 0.75, 90% CI [0.672 - 0.845]
AUCt:  PI = 0.82, 90% CI [0.754 - 1.042]

I am confusing to be sure that the test product is bad , so i am asking your help to know the real cause of these results.

Thank you in advance

Edit: Category changed; see also this post #1[Helmut]

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Tuesday 22:58 CEST (Europe/Vienna)

We have to remember that what we observe is not nature herself,
but nature exposed to our method of questioning.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz